Ardelyx Operating Cycle Over Time
| ARDX Stock | USD 7.10 0.28 3.79% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ardelyx Performance and Ardelyx Correlation. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ardelyx. If investors know Ardelyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Ardelyx assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.23) | Revenue Per Share | Quarterly Revenue Growth 0.123 | Return On Assets | Return On Equity |
Understanding Ardelyx requires distinguishing between market price and book value, where the latter reflects Ardelyx's accounting equity. The concept of intrinsic value - what Ardelyx's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Ardelyx's price substantially above or below its fundamental value.
Understanding that Ardelyx's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Ardelyx represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Ardelyx's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Cycle Analysis
Compare Ardelyx and related stocks such as Zymeworks Common Stock, Maze Therapeutics Common, and BioCryst Pharmaceuticals Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZYME | 663 | 663 | 663 | 663 | 663 | 85.5823 | 143 | 16.43 | 2.4646 | 26.9945 | 143 | 214 | 29.5552 | 93.5261 | 267 | 307 | 168 |
| MAZE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| BCRX | 72.1 K | 141 | (1.1 K) | (8.7 K) | 2.3 K | 358 | 189 | (8 K) | 1.4 K | 166 | 1.7 K | 862 | 1.6 K | 2.3 K | 300 | 346 | 328 |
| TRVI | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 22.2 K | 19.9 K | 17.7 K |
| SYRE | 102 | 102 | 102 | 102 | 102 | 102 | 95.8243 | 216 | 15.8746 | 15.8746 | 15.8746 | 15.8746 | 58.7699 | 58.7699 | 58.7699 | 67.59 | 107 |
| NTLA | 60.3905 | 60.3905 | 60.3905 | 60.3905 | 60.3905 | 60.3905 | 143 | 146 | 90.5124 | 39.1226 | 13.4057 | 22.4281 | 26.3871 | 367 | 53.7123 | 48.34 | 76.97 |
| PHVS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| WVE | 25.4509 | 25.4509 | 25.4509 | 25.4509 | 25.4509 | 98.5421 | 98.5421 | 98.5421 | 253 | 457 | 545 | 67.9263 | 67.9263 | 67.9263 | 4.7924 | 4.31 | 4.1 |
| STOK | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 17.3011 | 2.6606 | 6.9895 | 8.04 | 9.88 |
| UPB | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 36.1933 | 182 | 164 | 91.2 |
Ardelyx and related stocks such as Zymeworks Common Stock, Maze Therapeutics Common, and BioCryst Pharmaceuticals Operating Cycle description
My Equities
My Current Equities and Potential Positions
| Ardelyx | ARDX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 400 Fifth Avenue, |
| Exchange | NASDAQ Exchange |
USD 7.1
Additional Tools for Ardelyx Stock Analysis
When running Ardelyx's price analysis, check to measure Ardelyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ardelyx is operating at the current time. Most of Ardelyx's value examination focuses on studying past and present price action to predict the probability of Ardelyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ardelyx's price. Additionally, you may evaluate how the addition of Ardelyx to your portfolios can decrease your overall portfolio volatility.